SHH Healthcare Biotechnology 688520.SS

Sinocelltech Group Limited

$ 34.16 2.95 %

Sinocelltech Group Limited is a Beijing-based biotechnology enterprise. The company's primary focus lies in pioneering and refining the technologies required for both the creation and large-scale production of vital biological agents, specifically recombinant proteins, monoclonal antibodies, and vaccines, throughout China.

CEO: Liangzhi Xie - https://www.sinocelltech.com

Summary 30-Y Financials Dividend Analyst Key metrics Ownership / Senat
Price objectif

-

Recommandation

-

DCF

$ -347.22

Loading data...

688520.SS vs S&P500

Loading data...

No data available.

Quick ratio

0.85

indicates that the company may have difficulty covering its short-term debts with its readily available assets.

P/E ratio

-18.37

may indicate that the company is undervalued or has poor growth prospects.

EPS

-1.86

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

765.64 %

is generally considered excellent, indicating that the company is generating strong profits with its equity.

ROIC

-14.40 %

does not generate enough return to cover its financing costs, which indicates value destruction and may pose long-term profitability issues.

WACC

6.47

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

55.29

means it relies more on debt, which can increase financial risk.

Free cash flow per share

-1.20

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

-9.47 %

indicates that the company is retaining a large portion of its profits to reinvest in growth

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
3 indicates worrying financial health
Altman score
0.46 indicates a high risk of bankruptcy
Loading data...

No data available.

Cash / Debt

Cash Ratio
0.54 indicates that the company has a moderate ability to cover its short-term debts with its cash
Debt Ratio
0.86 indicates a moderate level of debt, which is generally acceptable but may present some risk
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.